Populations

Browse more sub-categories

Active Resources: 24

Articles: 1

  • Bictegravir/TAF/FTC in Women

    The single-pill combination of bictegravir (BIC) with tenofovir alafenamide (TAF) and emtricitabine (FTC), recently approved by the FDA, has been shown in four Phase III trials to be effective as initial therapy and as a switch regimen in patients with stably suppressed HIV RNA...

Day Title
9/21
Advancing Excellence in Transgender Health: A Core Course for the Whole Care Team
11/27
2018 Texas HIV-STD Conference
Day Title
7/15
National Commission on Correctional Healthcare: Spring Conference on Correctional Health Care